B3GAT3

beta-1,3-glucuronyltransferase 3, the group of Beta-1,3-glucuronyltransferases

Basic information

Region (hg38): 11:62615296-62622154

Links

ENSG00000149541NCBI:26229OMIM:606374HGNC:923Uniprot:O94766AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Larsen-like syndrome, B3GAT3 type (Limited), mode of inheritance: AR
  • Larsen-like syndrome, B3GAT3 type (Strong), mode of inheritance: AR
  • Larsen-like syndrome, B3GAT3 type (Moderate), mode of inheritance: AR
  • Larsen-like syndrome, B3GAT3 type (Strong), mode of inheritance: AR
  • Larsen-like syndrome, B3GAT3 type (Supportive), mode of inheritance: AR
  • complex neurodevelopmental disorder (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defectsARGeneralThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Craniofacial; Musculoskeletal21763480; 24668659

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the B3GAT3 gene.

  • Larsen-like_syndrome,_B3GAT3_type (220 variants)
  • not_provided (66 variants)
  • Inborn_genetic_diseases (53 variants)
  • B3GAT3-related_disorder (6 variants)
  • not_specified (4 variants)
  • MULTIPLE_JOINT_DISLOCATIONS,_SHORT_STATURE,_AND_CRANIOFACIAL_DYSMORPHISM_WITHOUT_CONGENITAL_HEART_DEFECTS (3 variants)
  • MULTIPLE_JOINT_DISLOCATIONS,_SHORT_STATURE,_AND_CRANIOFACIAL_DYSMORPHISM_WITH_CONGENITAL_HEART_DEFECTS (2 variants)
  • Multiple_joint_dislocations,_short_stature,_craniofacial_dysmorphism,_with_or_without_congenital_heart_defects (1 variants)
  • See_cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the B3GAT3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012200.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
64
clinvar
66
missense
6
clinvar
4
clinvar
118
clinvar
5
clinvar
1
clinvar
134
nonsense
3
clinvar
7
clinvar
1
clinvar
11
start loss
4
4
frameshift
6
clinvar
1
clinvar
1
clinvar
8
splice donor/acceptor (+/-2bp)
2
clinvar
2
Total 15 18 122 69 1

Highest pathogenic variant AF is 0.0000756514

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
B3GAT3protein_codingprotein_codingENST00000265471 56880
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.71e-80.2991257150301257450.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6921782060.8640.00001362087
Missense in Polyphen4754.9750.85493604
Synonymous-0.2269390.31.030.00000514768
Loss of Function0.5921315.50.8389.39e-7139

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001170.000117
Ashkenazi Jewish0.00009950.0000992
East Asian0.000.00
Finnish0.00004630.0000462
European (Non-Finnish)0.0001520.000149
Middle Eastern0.000.00
South Asian0.0001640.000163
Other0.0003310.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Glycosaminoglycans biosynthesis (PubMed:25893793). Involved in forming the linkage tetrasaccharide present in heparan sulfate and chondroitin sulfate. Transfers a glucuronic acid moiety from the uridine diphosphate-glucuronic acid (UDP-GlcUA) to the common linkage region trisaccharide Gal-beta-1,3-Gal-beta-1,4- Xyl covalently bound to a Ser residue at the glycosaminylglycan attachment site of proteoglycans. Can also play a role in the biosynthesis of l2/HNK-1 carbohydrate epitope on glycoproteins. Shows strict specificity for Gal-beta-1,3-Gal-beta-1,4-Xyl, exhibiting negligible incorporation into other galactoside substrates including Galbeta1-3Gal beta1-O-benzyl, Galbeta1- 4GlcNAc and Galbeta1-4Glc. Stimulates 2-phosphoxylose phosphatase activity of PXYLP1 in presence of uridine diphosphate-glucuronic acid (UDP-GlcUA) during completion of linkage region formation (PubMed:24425863). {ECO:0000269|PubMed:24425863, ECO:0000269|PubMed:25893793}.;
Disease
DISEASE: Multiple joint dislocations, short stature, and craniofacial dysmorphism with or without congenital heart defects (JDSCD) [MIM:245600]: An autosomal recessive disease characterized by dysmorphic facies, bilateral dislocations of the elbows, hips, and knees, clubfeet, and short stature, as well as cardiovascular defects. {ECO:0000269|PubMed:21763480, ECO:0000269|PubMed:24668659, ECO:0000269|PubMed:25893793, ECO:0000269|PubMed:26086840}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human);Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Proteoglycan biosynthesis;glycoaminoglycan-protein linkage region biosynthesis;chondroitin sulfate biosynthesis;heparan sulfate biosynthesis;dermatan sulfate biosynthesis;Metabolism (Consensus)

Recessive Scores

pRec
0.131

Intolerance Scores

loftool
0.600
rvis_EVS
-0.2
rvis_percentile_EVS
38.82

Haploinsufficiency Scores

pHI
0.248
hipred
N
hipred_score
0.291
ghis
0.567

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.434

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
B3gat3
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
b3gat3
Affected structure
pharyngeal arch 3-7
Phenotype tag
abnormal
Phenotype quality
shape

Gene ontology

Biological process
glycosaminoglycan biosynthetic process;protein glycosylation;heparan sulfate proteoglycan biosynthetic process;glycosaminoglycan metabolic process;positive regulation of catalytic activity;regulation of phosphoprotein phosphatase activity;chondroitin sulfate proteoglycan biosynthetic process;dermatan sulfate proteoglycan biosynthetic process;positive regulation of intracellular protein transport
Cellular component
Golgi membrane;Golgi apparatus;cis-Golgi network;membrane;integral component of membrane;extracellular exosome
Molecular function
protein binding;galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity;glucuronosyltransferase activity;metal ion binding;protein phosphatase activator activity